Transsynovial kinetics of indoprofen in patients with rheumatoid arthritis and cyclooxygenase-inhibition in vitro

Twenty-four patients suffering from rheumatoid arthritis and requiring articular punctures were treated with 200 mg of indoprofen thrice daily for four days. The subjects were divided into four groups each of six patients. Following the last dose, blood and synovial fluid samples were taken simultan...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of clinical pharmacology research Vol. 8; no. 4; p. 287
Main Authors Kurowski, M, Schiemann, A, Siebler, D
Format Journal Article
LanguageEnglish
Published Switzerland 1988
Subjects
Arthritis, Rheumatoid - drug therapy
Cyclooxygenase Inhibitors
Dinoprostone - biosynthesis
Female
Humans
Indomethacin - pharmacology
Indoprofen - blood
Indoprofen - pharmacokinetics
Indoprofen - pharmacology
Indoprofen - therapeutic use
Kinetics
Macrophages - enzymology
Male
Phenylpropionates - pharmacokinetics
Synovial Fluid - analysis
Time Factors
Online AccessGet more information

Cover

More Information
Summary:Twenty-four patients suffering from rheumatoid arthritis and requiring articular punctures were treated with 200 mg of indoprofen thrice daily for four days. The subjects were divided into four groups each of six patients. Following the last dose, blood and synovial fluid samples were taken simultaneously according to different time schedules. Maximum plasma levels of 17.5 micrograms/ml were observed after 2.5 h. Peak synovial fluid concentrations amounted to 8.1 micrograms/ml 4 h following the last dose. Elimination from synovial fluid occurred at 10.6 h compared to 9.3 h from plasma. Free synovial fluid levels of approximately 50 ng/ml are in the range of concentrations necessary for cyclooxygenase inhibition in mouse peritoneal macrophages.
ISSN:0251-1649